Download PDF
Previous article
Go back to website
If you have problems to see the content please click here
Other users also viewed these articles
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH¿AEG¿SEPD¿SEOM¿GETECCU
Mar Riveiro-Barciela; Sabela Carballal; Álvaro Díaz-González; Míriam Mañosa; Javier Gallego-Plazas; Joaquín Cubiella; Paula Jiménez-Fonseca; María Varela; Luis Menchén; Bruno Sangro; Ana Fernández-Montes; Francisco Mesonero; Miguel Ángel Rodríguez-Gandía; Fernando Rivera; María-Carlota Londoño;
Gastroenterol Hepatol. 2024;47:401-32
Hepatic silicosis as a rare cause of granulomatous liver disease
María Del Barrio; Maria Luisa Cagigal; Álvaro Díaz-González;
Gastroenterol Hepatol. 2025;48:
Artificial intelligence-assisted identification and retrieval of chronic hepatitis C patients lost to follow-up in the health area of Pontevedra and O Salnés (Spain)
Pablo Parada Vázquez; Santiago Pérez-Cachafeiro; Belén Castiñeira Domínguez; Juan Manuel González-Pérez; José Manuel Mera Calviño; Raquel Souto-Rodríguez; Yolanda Falagán Cachafeiro; Indhira Pérez-Medrano; Nuria Vázquez-Temprano; Matilde Trigo; Alba Carrodeguas; José Luis González-Sánchez; Carmen Durán-Parrondo; Juan Turnes;
Gastroenterol Hepatol. 2025;48: